最新ニュース Krispy Kreme (NASDAQ:DNUT) 株価情報

Krispy Kreme

Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.

Krispy Kreme Inc

Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.75) by 5.33 percent.

Earnings

Earnings Beats

News

RCKT

Rocket Pharmaceuticals Q3 2024 GAAP EPS $(0.71) Beats $(0.75) Estimate

CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) affirms FY2024 sales outlook from $225.00 million-235.00 million to $225.00 million-235.00 million.

Guidance

CYRX

CryoPort Affirms FY2024 Sales Guidance to $225.00M-235.00M  VS Est.229.73M

NV5 Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEE#NASDAQ">NVEE</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.41 by 7.32 percent. This is a 22.22 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $250.885 million which missed the analyst consensus estimate of $252.108 million by 0.49 percent. This is a 4.85 percent increase over sales of $239.287 million the same period last year.

Earnings Misses

NVEE

NV5 Global Q3 2024 Adj. EPS $0.44 Beats $0.41 Estimate, Sales $250.885M Miss $252.108M Estimate

FRLA

Fortune Rise Acquisition Extends To Complete Business Combination From Nov. 5 To Dec. 5

WIIM

PRPH

ProPhase Labs shares are trading lower after the company announced its intention to sell shares through a public offering.

Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.02 by 200 percent. The company reported quarterly sales of $213.300 million which beat the analyst consensus estimate of $210.729 million by 1.22 percent. This is a 11.15 percent increase over sales of $191.900 million the same period last year.

MYGN

Myriad Genetics Q3 2024 Adj. EPS $0.06 Beats $0.02 Estimate, Sales $213.300M Beat $210.729M Estimate

Buybacks

DVAX

Dynavax Launches $200M Share Buyback Program With Board Approval; Repurchases Expected To Be Completed Within One Year

ON24 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTF#NYSE">ONTF</a>) raises FY2024 Adj EPS guidance from $0.05-0.08 to $0.08-0.10 vs $0.07 analyst estimate. Raises FY2024 sales outlook from $145.00 million-147.80 million to $146.80 million-147.80 million vs $146.33 million estimate.

ONTF

ON24 Raises FY2024 Adj EPS Guidance from $0.05-0.08 to $0.08-0.10 vs $0.07 Est; Raises FY2024 Sales Guidance from $145.00M-147.80M to $146.80M-147.80M vs $146.33M Est

Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) affirms FY2024 sales outlook from $1.40 billion-1.60 billion to $1.40 billion-1.60 billion.

Bloom Energy Affirms FY2024 Sales Guidance to $1.40B-1.60B  VS Est.1.47B

Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 90 percent increase over losses of $(2.50) per share from the same period last year. The company reported quarterly sales of $665.00 thousand which missed the analyst consensus estimate of $1.31 million by 49.24 percent. This is a 46.88 percent decrease over sales of $1.25 million the same period last year.

PHUN

Phunware Q3 EPS $(0.25) Beats $(0.26) Estimate, Sales $665.00K Miss $1.31M Estimate

Apartment Inv &amp; Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIV#NYSE">AIV</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 700 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $53.16 million which beat the analyst consensus estimate of $52.60 million by 1.06 percent. This is a 11.44 percent increase over sales of $47.70 million the same period last year.

Apartment Inv & Mgmt Q3 EPS $(0.16) Misses $(0.11) Estimate, Sales $53.16M Beat $52.60M Estimate

New facility will enable testing of liquid hydrogen (LH2), liquid oxygen (LOX) and liquid methane (LCH4)

Graham To Construct Cryogenic Propellant Testing Facility

ON24 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTF#NYSE">ONTF</a>) is looking for Q4 Adj EPS of $0.01-0.02 vs $0.01 analyst estimate. sees sales of $35.400 million-36.400 million vs $35.87 million estimate.

ON24 Sees Q4 Adj EPS $0.01-0.02 vs $0.01 Est; Sees Sales $35.400M-36.400M vs $35.87M Est

MRVI

Maravai LifeSciences To Acquire Officinae Bio's DNA And RNA Business, Enhancing Nucleic Acid Research Capabilities; Acquisition To Boost Maravai's mRNA Manufacturing Through TriLink BioTechnologies

Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.06) by 550 percent. This is a 750 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $823.70 million which beat the analyst consensus estimate of $748.00 million by 10.12 percent.

LION

Lionsgate Studios Q2 2025 GAAP EPS $(0.39) Misses $(0.06) Estimate, Sales $823.70M Beat $748.00M Estimate

Lantronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>) is looking for Q2 Adj EPS of $0.01-0.05 vs $0.10 analyst estimate. sees sales of $29.000 million-33.000 million vs $38.60 million estimate.

LTRX

Lantronix Sees Q2 Adj EPS $0.01-0.05 vs $0.10 Est; Sees Sales $29.000M-33.000M vs $38.60M Est

FIGS

FIGS shares are trading lower after the company reported worse-than-expected Q3 revenue results and cut its FY24 revenue guidance.

BlackLine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BL#NASDAQ">BL</a>) is looking for Q4 Adj EPS of $0.47-0.52 vs $0.51 analyst estimate. seessales of $167.000 million-169.000 million vs $168.08 million estimate.

BlackLine Sees Q4 Adj EPS $0.47-0.52 vs $0.51 Est; Sees Sales $167.000M-169.000M vs $168.08M Est

Adeia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADEA#NASDAQ">ADEA</a>) lowers FY2024 sales outlook from $380.00 million-420.00 million to $370.00 million-400.00 million.

ADEA

Adeia Lowers FY2024 Sales Guidance from $380.00M-420.00M to $370.00M-400.00M

Longboard Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBPH#NASDAQ">LBPH</a>) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.57) by 10.53 percent.

LBPH

Longboard Pharmaceuticals Q3 2024 GAAP EPS $(0.63) Misses $(0.57) Estimate

BofA analyst Sara Senatore raised the firm's price target on Krispy Kreme (DNUT) to $16 from $15 and keeps a Buy rating on the shares. The firm is ...

Krispy Kreme price target raised to $16 from $15 at BofA

In a report released today, Sara Senatore from Bank of America Securities maintained a Buy rating on Krispy Kreme (DNUT – Research Report). The com...

Bank of America Securities Reaffirms Their Buy Rating on Krispy Kreme (DNUT)

White Brook Capital Partners Q3 2024 Commentary

Baron Focused Growth Fund Q3 2024 Shareholder Letter

In a report released today, Brian Harbour from Morgan Stanley maintained a Hold rating on Krispy Kreme (DNUT – Research Report), with a price targe...

Cautious Optimism: Krispy Kreme's Strategic Partnerships and Execution Risks Lead to Hold Rating

Morgan Stanley resumed coverage of Krispy Kreme (DNUT) with an Equal Weight rating and $14 price target The company's McDonald's partnership is an ...

Krispy Kreme resumed with an Equal Weight at Morgan Stanley

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Dollar Tree downgraded, eBay upgraded: Wall Street's top analyst calls

Krispy Kreme Q3 2024 Earnings Preview

&nbsp;Krispy Kreme misses Q3 estimates

Krispy Kreme misses the sweet spot as profits fall flat, outlook lowered

ABNB

ACGL

AFYA

ALRM

BCAP

BIRK

BLDR

BROE

CNTY

CSGP

CVNA

DLTR

DNUT

EBAY

FSLR

FSUN

GPRE

GWRE

HMST

HUBB

IBKR

IDXX

IDYA

ILMN

MSCI

OKTA

ONON

PETQ

ROIC

SHOP

SPOT

TSLA

Press Releases

KRISPY KREME® Introduces Golden Harvest Collection, All-New Flavors to Savor Just in Time for Fall

KRISPY KREME® Returns Iconic Pumpkin Spice Original Glazed® Doughnut for Three Days Only This Weekend to Celebrate Fall's Official Arrival

KRISPY KREME® Treats Fans to FREE Hot or Iced Coffee on National Coffee Day, Sunday, Sept. 29

Capture Your Cravings This Halloween! KRISPY KREME'S® Ghostbusters Collection Celebrates 1984 Film's 40th Anniversary

KRISPY KREME® Celebrates First Phase of Expansion to Local McDonald's Restaurants by Giving FREE Doughnuts to All McDonald's Lovers

KRISPY KREME® Celebrates Biggest Supermoon of 2024 with New Supermoon Super Doughnut, Available Only Oct. 17

Krispy Kreme, Inc. to Announce Third Quarter 2024 Results on November 7, 2024

KRISPY KREME® to Sweeten Election Day Nov. 5 With FREE Original Glazed® Doughnut for All Guests

KRISPY KREME's® All-New Thanksgiving Pies Doughnut Collection Sweetens the Season With a New Spin on Holiday Tradition

Krispy Kreme Reports Third Quarter 2024 Financial Results

Arcos Dorados Holdings Inc. Class A Shares

Arcos Dorados Holdings

Aramark

Bloomin Brands

Dutch Bros

The Cheesecake Factory Incorporated - Common Stock

Cheesecake Factory

Cava Group

Cracker Barrel Old Country Store, Inc. - Common Stock

Cracker Barrel Old

Chipotle Mexican Grill, Inc. Common Stock

Chipotle Mexican Grill

DoorDash

Domino's Pizza

Darden Restaurants

Brinker International

First Watch Restaurant Group, Inc. - Common Stock

First Watch Restaurant Gr

SUPER HI INTERNATIONAL HOLDING LTD. - American Depositary Shares

Super Hi International

Kura Sushi USA, Inc. - Class A Common Stock

Kura Sushi USA

McDonald's

Papa John's International, Inc. - Common Stock

Papa John's International

Starbucks

Sweetgreen

Shake Shack

Texas Roadhouse

Wendy's

Wingstop

Yum Brands

Yum China Holdings

B of A Securities

Evercore ISI Group

HSBC

Truist Securities

JP Morgan

Krispy Kreme shares are trading lower after the company reported worse-than-expected Q3 EPS and sales.

Comments

Krispy Kreme

ニュース

最新ニュース Krispy Kreme (NASDAQ:DNUT) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル